APA (7th ed.) Citation

Liu Y, Wu M, Xu B, & Kang L. (2021). Empagliflozin Alleviates Atherosclerosis Progression by Inhibiting Inflammation and Sympathetic Activity in a Normoglycemic Mouse Model. Dove Medical Press.

Chicago Style (17th ed.) Citation

Liu Y, Wu M, Xu B, and Kang L. Empagliflozin Alleviates Atherosclerosis Progression by Inhibiting Inflammation and Sympathetic Activity in a Normoglycemic Mouse Model. Dove Medical Press, 2021.

MLA (9th ed.) Citation

Liu Y, et al. Empagliflozin Alleviates Atherosclerosis Progression by Inhibiting Inflammation and Sympathetic Activity in a Normoglycemic Mouse Model. Dove Medical Press, 2021.